New drug target for cancer

Scientists have developed a new drug that blocks a transcription factor -- previously thought to be un-blockable -- that has been causally linked to leukemia and several other cancers of the lungs, ovaries, pancreas, and gastrointestinal tract, they report in linkurl:Nature;http://www.nature.com/nature/index.html this week. Bone marrow smear showing acute lymphoblastic leukemia Image: Furfur, Wikimedia Commons The Notch transcription factor regulates cell-cell communication in the Notch signal

Katherine Bagley
Nov 10, 2009
Scientists have developed a new drug that blocks a transcription factor -- previously thought to be un-blockable -- that has been causally linked to leukemia and several other cancers of the lungs, ovaries, pancreas, and gastrointestinal tract, they report in linkurl:Nature;http://www.nature.com/nature/index.html this week.
Bone marrow smear showing acute
lymphoblastic leukemia

Image: Furfur, Wikimedia Commons
The Notch transcription factor regulates cell-cell communication in the Notch signaling pathway, a system governing cell growth and development. Mutations in the transcription factor can result in uncontrolled cell growth, often causing cells to turn cancerous. But transcription factors are notoriously hard for medicinal chemists to target because they work by forming complexes with multiple proteins, leaving no open binding sites for small molecules to fit into. "It's exciting research," said linkurl:Andrew Weng,;http://www.terryfoxlab.ca/people/aweng/andrew.aspx a molecular biologist at the British Columbia Cancer Agency in Canada, who was not involved in the study. "A lot of...




Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?